Related Experiment Video

Updated: Jun 24, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Cardiac biomarkers and the case for point-of-care testing

Barry McDonnell1, Stephen Hearty, Paul Leonard

  • 1Biomedical Diagnostics Institute, Dublin City University, Dublin, Ireland.

Clinical Biochemistry
|March 26, 2009
PubMed

Insights

Cardiovascular disease (CVD) is a major cause of death. This study evaluates cardiac biomarkers for early detection and risk prediction, highlighting the role of point-of-care testing in improving cardiac care.

Area of Science:

  • Biomedical research
  • Cardiology
  • Medical diagnostics

Background:

  • Cardiovascular disease (CVD) is a leading cause of adult mortality, imposing significant healthcare and economic burdens.
  • Inefficient early detection, misdiagnosis, and lack of clear risk assessment criteria exacerbate the CVD problem.
  • Current research focuses on identifying cardiac biomarkers for improved CVD detection and risk stratification.

Purpose of the Study:

  • To evaluate the status and potential of cardiac biomarkers in early CVD risk prediction.
  • To assess biomarkers as diagnostic markers for acute myocardial damage.
  • To examine the role of biomarkers as prognostic indicators in cardiovascular disease.

Main Methods:

  • Literature review of consistently cited cardiac biomarkers.
  • Analysis of biomarker utility in risk stratification and diagnosis.
  • Critical discussion of early prediction strategies and point-of-care (POC) testing.

Main Results:

  • Several cardiac biomarkers show promise for early CVD risk prediction.
  • Biomarkers can enhance the accuracy of diagnosing acute myocardial damage.
  • Biomarkers serve as reliable prognostic indicators for cardiovascular conditions.

Conclusions:

  • Cardiac biomarkers are crucial for advancing cardiovascular disease management.
  • Point-of-care (POC) testing is poised to revolutionize future cardiac care through early detection.
  • Improved risk assessment and early detection via biomarkers can reduce CVD mortality and healthcare costs.

More Related Videos

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum09:23

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...